Malakoplakia

Malakoplakia is a rare inflammatory condition that can affect various organs in the body. It is characterized by the presence of unique histiocytes, known as Michaelis-Gutmann bodies, in the affected tissues. The condition was first described by Michaelis and Gutmann in 1902.

Etiology[edit | edit source]

The exact cause of malakoplakia is not known, but it is believed to be associated with an abnormal immune response to bacterial infections, particularly those caused by the E. coli bacterium. Other bacteria, such as Proteus and Rhodococcus, have also been implicated.

Pathogenesis[edit | edit source]

The pathogenesis of malakoplakia involves the accumulation of histiocytes in the affected tissues. These histiocytes contain unique inclusions known as Michaelis-Gutmann bodies, which are thought to be the result of defective phagocytosis and intracellular digestion of bacteria.

Clinical Features[edit | edit source]

The clinical features of malakoplakia can vary depending on the organ involved. In the urinary tract, which is the most common site of involvement, symptoms may include hematuria, dysuria, and lower abdominal pain. In other organs, such as the gastrointestinal tract or lungs, symptoms may be non-specific and include weight loss, fever, and malaise.

Diagnosis[edit | edit source]

The diagnosis of malakoplakia is typically made based on the histological examination of a biopsy specimen, which reveals the characteristic Michaelis-Gutmann bodies. Other diagnostic tests, such as urine culture or imaging studies, may also be used to identify the underlying bacterial infection or to assess the extent of the disease.

Treatment[edit | edit source]

The treatment of malakoplakia involves the use of antibiotics to eradicate the underlying bacterial infection. In some cases, surgical intervention may be necessary to remove the affected tissues.

Prognosis[edit | edit source]

The prognosis of malakoplakia is generally good, especially when the disease is diagnosed and treated early. However, in some cases, the disease can be progressive and lead to serious complications, such as renal failure or sepsis.

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Translate this page: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.